Menu
Return To Home
ACR 2016
View Reports
Archive by Day
RheumReporters
All Meetings
About RheumReports
Contact Us
Past Coverage of ACR 2016
Past Coverage of ACR 2016
Return To RheumReports Home
ACR 2016
Archive
RheumReporter Bios
About RheumReports
Contact Us
Today's Featured
3 new reports
Loading
Connection Failure
RheumReports thanks our sponsors: Janssen, Celgene, Pfizer, Merck, Amgen and AbbVie
NOVEMBER 16
Featured
ACR Final Highlights
7:35 PM ET
— via Dr. Shelly Dunne
Sponsored Content
Opportunities and Challenges in the Era of Biosimilars
7:35 PM ET
— via RheumReports
The Depressing Truth About Lupus
4:00 PM ET
— via Dr. Stephanie Keeling
Parting Ways with Prednisone: Are Steroids Really Necessary in the Treatment of Myositis?
3:00 PM ET
— via Dr. Pari Basharat
Direct to Consumer Advertising and its Effects
3:00 PM ET
— via Dr. Janet Pope
Featured
Five RA Take-Home Messages From the ACR for New Drugs and Treatment Strategies
2:50 PM ET
— via Dr. Janet Pope
Take the Lupus Biological Target Test!
2:30 PM ET
— via Dr. Stephanie Keeling
Time is Muscle: Treatment Trends in Juvenile Dermatomyositis
2:00 PM ET
— via Dr. Pari Basharat
Take Home Messages from RA Posters
1:00 PM ET
— via Dr. Andy Thompson
Inflammatory Myopathy with ILD is Seasonal!
1:00 PM ET
— via Dr. Pari Basharat
Weak in the Knees, Heart Skips a Beat: Cardiac Involvement in Myositis
12:09 PM ET
— via Dr. Pari Basharat
Explosion of Therapeutic Options for Axial SpA
12:08 PM ET
— via Dr. Shelly Dunne
Sponsored Content
Biosimilars: A Hot Topic at ACR 2016
12:07 PM ET
— via RheumReports
Featured
A New Prednisone for Lupus Nephritis
11:00 AM ET
— via Dr. Pari Basharat
Featured
Seven Top Pregnancy Tips from ACR 2016
11:00 AM ET
— via Dr. Stephanie Keeling
Fat, Exercise, Inflammation and More
11:00 AM ET
— via Marlene Thompson
Osteoporosis Update Part 2: Anabolic Therapy
11:00 AM ET
— via Marlene Thompson
Featured
Rituximab is the GOLD Standard for Maintenance Therapy in ANCA Vasculitis
11:00 AM ET
— via Dr. Andy Thompson
NOVEMBER 15
Head to Head: Failure of Certolizumab to be Superior to Adalimumab in Active RA
7:06 PM ET
— via Dr. Janet Pope
Microbiome Affects Response to Methotrexate in Early RA. Is it All a Load of Crap?
6:49 PM ET
— via Dr. Janet Pope
Current Event
RheumReports is made possible through the support of our sponsors.
Loading
All reports loaded
Connection Failure